Profile
Full Name
Bio-Rad Laboratories, Inc.Ticker Symbol
BIOExchange
NYSESector
HealthcareIndustry
Medical DevicesCountry
United StatesIPO
February 27, 1980Indexes
Not includedWebsite
http://www.bio-rad.comEmployees
7700Key Details
Price
$234.75
Market Cap
$6.58B(Mid cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$2.57B(-3.92% YoY)
Annual EPS
-$65.36(-199.54% YoY)
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Bio-Rad Laboratories doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 12, 25 Wells Fargo
Equal-WeightJan 14, 25 RBC Capital
OutperformDec 9, 24 RBC Capital
OutperformOct 31, 24 RBC Capital
OutperformOct 31, 24 Citigroup
BuyOct 1, 24 Citigroup
BuyAug 27, 24 Wells Fargo
Equal-WeightAug 16, 24 RBC Capital
OutperformAug 2, 24 RBC Capital
OutperformAug 2, 24 Citigroup
NeutralInstitutional Ownership
- What is the ticker symbol for Bio-Rad Laboratories?
- Does Bio-Rad Laboratories pay dividends?
- What sector is Bio-Rad Laboratories in?
- What industry is Bio-Rad Laboratories in?
- What country is Bio-Rad Laboratories based in?
- When did Bio-Rad Laboratories go public?
- Is Bio-Rad Laboratories in the S&P 500?
- Is Bio-Rad Laboratories in the NASDAQ 100?
- Is Bio-Rad Laboratories in the Dow Jones?
- When was Bio-Rad Laboratories's last earnings report?
- When does Bio-Rad Laboratories report earnings?
- Should I buy Bio-Rad Laboratories stock now?
What is the ticker symbol for Bio-Rad Laboratories?
The ticker symbol for Bio-Rad Laboratories is NYSE:BIO
Does Bio-Rad Laboratories pay dividends?
No, Bio-Rad Laboratories does not pay dividends
What sector is Bio-Rad Laboratories in?
Bio-Rad Laboratories is in the Healthcare sector
What industry is Bio-Rad Laboratories in?
Bio-Rad Laboratories is in the Medical Devices industry
What country is Bio-Rad Laboratories based in?
Bio-Rad Laboratories is headquartered in United States
When did Bio-Rad Laboratories go public?
Bio-Rad Laboratories's initial public offering (IPO) was on February 27, 1980
Is Bio-Rad Laboratories in the S&P 500?
No, Bio-Rad Laboratories is not included in the S&P 500 index
Is Bio-Rad Laboratories in the NASDAQ 100?
No, Bio-Rad Laboratories is not included in the NASDAQ 100 index
Is Bio-Rad Laboratories in the Dow Jones?
No, Bio-Rad Laboratories is not included in the Dow Jones index
When was Bio-Rad Laboratories's last earnings report?
Bio-Rad Laboratories's most recent earnings report was on Feb 13, 2025
When does Bio-Rad Laboratories report earnings?
The next expected earnings date for Bio-Rad Laboratories is May 7, 2025
Should I buy Bio-Rad Laboratories stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions